TMCnet News
CEN Biotech Appoints John A. Germinario as Chairman of the Board [Global Data Point](Global Data Point Via Acquire Media NewsEdge) As a seasoned banker with over 33 years of experience in global capital markets, Mr. Germinario will be managing a variety of immediate tasks including regulatory compliance, risk management, corporate governance, potential mergers and acquisitions, assessing market strategy and spearheading financing activities. "Our association with Mr. Germinario marks the first step in our relationship with Push Point Management Group and we are extremely pleased to have John as our Chairman. Our Board of Directors unanimously voted for his appointment given his expertise, leadership and results-driven track record," commented Bill Chaaban, President %7E CEO. "His corporate ethics and entrepreneurial skills are valuable in establishing our long term vision and we are confident that his contributions will further enhance our shareholder value." Mr. Germinario currently serves as CEO of Global Securities Services Corporation an international strategic institution focused on designing and implementing Depositary Receipt Programs for publicly traded companies. Prior to joining CEN Biotech, Mr. Germinario was a global capital markets securities fraud examiner and worked with the U.S. Securities and Exchange Commission (SEC) and the Internal Revenue Service (IRS) Whistleblower to identify multiple levels of securities, bank and tax fraud, resulting in the collection of hundreds of millions of dollars in unpaid taxes by four major New York banks. Mr. Germinario continues to work with the SEC, Federal Bureau of Investigation (FBI) and the IRS on criminal investigations in an effort to provide a safe and secure share ownership experience for investors and shareholders. (c) 2014 GlobalData Provided by Syndigate.info, an Albawaba.com company [ Back To TMCnet.com's Homepage ] |